Real-world experience of emicizumab prophylaxis in young children with haemophilia A in China: retrospective data from China

被引：0
|
作者：
Huang, Kun [1 ]
Liu, Guoqing [1 ]
Wu, Runhui [1 ]
Chen, Zhenping [1 ]
Zhen, Yingzi [1 ]
Wu, Xinyi [1 ]
机构：
[1] Beijing Childrens Hosp, Beijing, Peoples R China
来源：
HAEMOPHILIA | 2022年 / 28卷
关键词：
emicizumab; FVIII inhibitor; haemophilia A;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FP-09.02 (
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [1] Real-world experience of emicizumab prophylaxis in young children with hemophilia A: retrospective data from China
    Liu, Guoqing
    Huang, Kun
    Li, Gang
    Zhen, Yingzi
    Li, Zhengping
    Chen, Zhenping
    Wu, Runhui
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [2] Real-world data of prophylaxis with emicizumab in children and adolescents with severe haemophilia: A single centre experience
    Michalopoulou, A.
    Dettoraki, A.
    Karelioti, H.
    Thymianou, S.
    Papageorgiou, N.
    Stamati, I.
    Saslis, S.
    Kapsimali, Z.
    Pergantou, H.
    HAEMOPHILIA, 2024, 30 : 61 - 61
  • [3] EMICIZUMAB PROPHYLAXIS IN HAEMOPHILIA A WITH AND WITHOUT INHIBITORS: REAL-WORLD DATA FROM SLOVENIA
    Rener, K.
    Doma, S. Anzej
    Kotnik, B. Faganel
    Kitanovski, L.
    Fink, M.
    Zupan, I. Preloznik
    HAEMOPHILIA, 2021, 27 : 70 - 70
  • [4] INVASIVE PROCEDURES IN PATIENTS WITH HAEMOPHILIA ON EMICIZUMAB PROPHYLAXIS: REAL-WORLD CLINICAL EXPERIENCE IN SLOVENIA
    Rener, K.
    Pompe, B.
    Doma, S. Anzej
    Kotnik, B. Faganel
    Kitanovski, L.
    Zupan, I. Preloznik
    HAEMOPHILIA, 2022, 28 : 66 - 66
  • [5] Real-world experience of emicizumab prophylaxis in children with severe haemophilia A: I year follow-up study in egypt
    Sherief, L.
    Hassan, A. S.
    Hamdy, M.
    Darwish, A.
    Nazim, A.
    Hussein, M. A.
    Elgendy, M. R.
    El-assy, O. A.
    HAEMOPHILIA, 2024, 30 : 121 - 121
  • [6] Real-world data on emicizumab prophylaxis in the Milan cohort
    Arcudi, Sara
    Gualtierotti, Roberta
    Marino, Sonia
    Nicolo, Gabriella
    Biguzzi, Eugenia
    Ciavarella, Alessandro
    Boscarino, Marco
    Siboni, Simona Maria
    Schiavone, Lucia
    Novembrino, Cristina
    Valsecchi, Carla
    Peyvandi, Flora
    HAEMOPHILIA, 2022, 28 (05) : E141 - E144
  • [7] Towards tailoring the use of emicizumab for haemophilia A children in China: A retrospective clinical data from a comprehensive care centre of China
    Mao, Qianqian
    Chen, Zhenping
    Wu, Runhui
    Poon, Man-Chiu
    Li, Gang
    Liu, Guoqing
    Cheng, Xiaoling
    Yao, Wanru
    Di, Ai
    Li, Zhengping
    Zhen, Yingzi
    Wang, Nan
    HAEMOPHILIA, 2024, 30 : 110 - 112
  • [8] Transitioning patients with severe haemophilia A from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: Real-world clinical experience
    Klamroth, Robert
    Gottstein, Saskia
    HAEMOPHILIA, 2024, 30 (05) : 1247 - 1249
  • [9] Real-world experience of emicizumab prophylaxis in Korean children with severe hemophilia A without inhibitors
    Kim, Sung Eun
    Kim, Ji Yoon
    Park, Jeong A.
    Lyu, Chuhl Joo
    Hahn, Seung Min
    Han, Jung Woo
    Park, Young Shil
    BLOOD RESEARCH, 2024, 59 (01)
  • [10] REAL-WORLD DATA ON EMICIZUMAB PROPHYLAXIS IN THE MILAN COHORT: A SINGLE-CENTER EXPERIENCE
    Arcudi, S.
    Gualtierotti, R.
    Ciavarella, A.
    Marino, S.
    Siboni, S.
    Biguzzi, E.
    Boccalandro, E.
    Begnozzi, V.
    Schiavone, L.
    Novembrino, C.
    Valsecchi, C.
    Peyvandi, F.
    HAEMOPHILIA, 2022, 28 : 84 - 84
12345